Time-Restricted eating: a new way to ease chemo side effects?

NCT ID NCT07387445

Recruiting now Symptom relief Sponsor: University of Illinois at Chicago Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether time-restricted eating (eating all food within an 8-hour window each day) is feasible and helpful for women undergoing chemotherapy for early-stage breast cancer. Forty participants will either follow this eating pattern or a usual diet for 24 weeks. Researchers will track how well people stick to the diet, and measure quality of life, fatigue, and side effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: time restricted eating (8-hour eating window, 16-hour fasting)
What this could lead to: If it works, this could offer a simple, drug-free way to reduce fatigue and improve quality of life during chemotherapy for breast cancer.
What could go wrong: This is a small, early feasibility study with only 40 participants, so results may not apply widely. It tests a behavioral change, not a drug, so benefits may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm Fasting Intermittent Fasting

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER BREAST CANCER EARLY STAGE BREAST CANCER (STAGE 1-3) BREAST NEOPLASM FEMALE

Contacts and locations

Locations

Robert H. Lurie Comprehensive Cancer Center
RECRUITING

Chicago, Illinois, 60611, United States
University of Illinois Chicago
RECRUITING

Chicago, Illinois, 60612, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.